Jilin Province Huinan Changlong Bio-pharmacy ompany Limited and its subsidiaries dated 31 March 2020 in relation to unaudited annual results of the Group for the year ended 31 December 2019. The auditing process for the annual results of the Group for the year ended 31 December 2019 has not been completed due to the restrictions in force in parts of China to combat the outbreak of COVID-19. The board of directors (the "Board") of the Company announces that upon discussion with the external independent auditor of the Company and comprehensive consideration of the auditing progress of the audited annual results of the Group for the year ended 31 December 2019 and the 2019 annual report, the Company is applying for a further time extension of the publication of the audited annual results and the 2019 annual report as the external independent auditor of the Company requires additional time to complete the relevant auditing process. The company expects that the auditing process will be completed on or before 8 June 2020, and the audited annual results of the Group for the year ended 31 December 2019 and the 2019 annual report will be published and/or despatched on or before 9 June 2020. The company will issue further announcement as when necessary if there are other material developments in the completion of the auditing process, publication of the audited annual results for the year ended 31 December 2019 and despatch of the 2019 annual report.